Carrier Screening Landscape Assessment
Clinical Diagnostics
25
8
>20
Voice-of-Customer Research
Objective
A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy
Our Approach
Secondary Research
- Reviewed company financial information (e.g., 10-K, 10-Q, earnings call transcripts, company presentations, and press releases) for all publicly-traded companies participating in the carrier screening space
- Gathered data around annual birth rates and relative carrier screening utilization by region as basis for the global market model
- Reviewed product specifications of competing vendors to understand menu offerings, test prices and technological approaches
Primary Research
- Conducted 25 in-depth stakeholder interviews with HCPs (OBGYNs and MFMs), Genetic Counselors, test vendors and reimbursement specialists in multiple settings across the U.S., Canada and the EU-5
Quantitative Analysis
- Built a “bottoms-up” model to estimate the global carrier screening service market, including:
- Global market size estimates from 2017 to 2027
- Segmentation by geography, test menu, testing location, tech type, test technology, competitor and price
Outcome
Key takeaways from DeciBio’s presentation to the client team included:
- Characterization of the carrier screening testing process, including test ordering decision, vendor selection, requisition procedure and reimbursement policies
- Identification of areas of opportunity within the saturated carrier screening market, including bundling with NIPT
- Walk-through of global market model and adjustable assumptions
Related Client Results
Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform
Target Identification
Internal Lab Buildout Strategy
Voice-of-Customer Research
Due Diligence
RWD Biobank Offering Go-to-Market Strategy
Voice-of-Customer Research
Go-to-Market Strategy
Pricing Strategy
Competitive Analysis